about
Recommendations for Optimizing Tuberculosis Treatment: Therapeutic Drug Monitoring, Pharmacogenetics, and Nutritional Status ConsiderationsActive transforming growth factor-β is associated with phenotypic changes in granulomas after drug treatment in pulmonary tuberculosisEstimated rates of recurrence, cure, and treatment abandonment in patients with pulmonary tuberculosis treated with a -four-drug fixed-dose combination regimen at a tertiary health care facility in the city of Rio de Janeiro, Brazil.Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosisNew Players in Immunity to Tuberculosis: The Host Microbiome, Lung Epithelium, and Innate Immune Cells.
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Treatment of Drug Susceptible Pulmonary Tuberculosis
@ast
Treatment of Drug Susceptible Pulmonary Tuberculosis
@en
Treatment of Drug Susceptible Pulmonary Tuberculosis
@nl
type
label
Treatment of Drug Susceptible Pulmonary Tuberculosis
@ast
Treatment of Drug Susceptible Pulmonary Tuberculosis
@en
Treatment of Drug Susceptible Pulmonary Tuberculosis
@nl
prefLabel
Treatment of Drug Susceptible Pulmonary Tuberculosis
@ast
Treatment of Drug Susceptible Pulmonary Tuberculosis
@en
Treatment of Drug Susceptible Pulmonary Tuberculosis
@nl
P2860
P3181
P1476
Treatment of Drug Susceptible Pulmonary Tuberculosis
@en
P2093
Hong-Joon Shin
Yong-Soo Kwon
P2860
P3181
P356
10.4046/TRD.2015.78.3.161
P407
P577
2015-07-01T00:00:00Z